567 related articles for article (PubMed ID: 29016487)
21. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.
Kearon C
J Thromb Thrombolysis; 2011 Apr; 31(3):295-300. PubMed ID: 21331558
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
[TBL] [Abstract][Full Text] [Related]
23. Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance.
Mantha S; Sarasohn D; Ma W; Devlin SM; Chi DS; Roche KL; Suidan RS; Woo K; Soff GA
Am J Obstet Gynecol; 2015 Aug; 213(2):208.e1-4. PubMed ID: 25743130
[TBL] [Abstract][Full Text] [Related]
24. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study.
Galanaud JP; Sevestre MA; Pernod G; Genty C; Richelet S; Kahn SR; Boulon C; Terrisse H; Quéré I; Bosson JL
J Thromb Haemost; 2017 May; 15(5):907-916. PubMed ID: 28266773
[TBL] [Abstract][Full Text] [Related]
26. A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism.
Oktaviana J; Lui B; Ho P; Lim HY
Blood Coagul Fibrinolysis; 2023 Apr; 34(3):191-198. PubMed ID: 36966765
[TBL] [Abstract][Full Text] [Related]
27. Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital.
Jørgensen CT; Tavoly M; Førsund E; Pettersen HH; Tjønnfjord E; Ghanima W; Brækkan SK
J Thromb Haemost; 2023 Oct; 21(10):2824-2832. PubMed ID: 37394122
[TBL] [Abstract][Full Text] [Related]
28. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
[TBL] [Abstract][Full Text] [Related]
29. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation.
Prandoni P; Lensing AW; Prins MH; Pesavento R; Piccioli A; Sartori MT; Tormene D; Milan M; Vedovetto V; Noventa F; Villalta S; Harenberg J
Semin Thromb Hemost; 2015 Mar; 41(2):133-40. PubMed ID: 25682083
[TBL] [Abstract][Full Text] [Related]
30. Treating patients with cancer and acute venous thromboembolism.
Donadini MP; Squizzato A; Ageno W
Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
[TBL] [Abstract][Full Text] [Related]
31. Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
Brown C; Brandt W; Wang TF; Delluc A; Carrier M
Thromb Res; 2023 Aug; 228():81-84. PubMed ID: 37301116
[TBL] [Abstract][Full Text] [Related]
32. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP;
Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685
[TBL] [Abstract][Full Text] [Related]
34. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.
Anand SS
Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396
[TBL] [Abstract][Full Text] [Related]
36. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
Goldhaber SZ; Ageno W; Casella IB; Chee KH; Schellong S; Singer DE; Desch M; Reilly PA; Donado E; Tang W; Voccia I; Schulman S
Am J Med; 2020 Aug; 133(8):936-945. PubMed ID: 32325043
[TBL] [Abstract][Full Text] [Related]
37. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
Boutitie F; Pinede L; Schulman S; Agnelli G; Raskob G; Julian J; Hirsh J; Kearon C
BMJ; 2011 May; 342():d3036. PubMed ID: 21610040
[TBL] [Abstract][Full Text] [Related]
38. Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Thromb Res; 2019 May; 177():1-9. PubMed ID: 30825719
[TBL] [Abstract][Full Text] [Related]
39. Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study.
Napolitano M; Saccullo G; Malato A; Sprini D; Ageno W; Imberti D; Mascheroni D; Bucherini E; Gallucci P; D'Alessio A; Prantera T; Spadaro P; Rotondo S; Di Micco P; Oriana V; Urbano O; Recchia F; Ghirarduzzi A; Lo Coco L; Mancuso S; Casuccio A; Rini GB; Siragusa S
J Clin Oncol; 2014 Nov; 32(32):3607-12. PubMed ID: 25267738
[TBL] [Abstract][Full Text] [Related]
40. Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital.
Jørgensen CT; Brækkan SK; Førsund E; Pettersen HH; Tjønnfjord E; Ghanima W; Tavoly M
J Thromb Haemost; 2024 Feb; 22(2):526-533. PubMed ID: 37913911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
